Philippe Camus, M.D.

Dijon, France

Back

The Drug-Induced Respiratory Disease Website

II.a

II - Myocardial dysfunction - Heart failure

Left ventricular dysfunction/failure

Last update 17/06/2026

De novo chronic, progressive or acute LV dysfunction/failure. May result from myocarditis or eosinophilic myocarditis. May cause congestive heart failure and/or pulmonary edema (see under II). Hypertension may be present. Symptoms range from worsening of preexisting LVF to acute cardiogenic pulmonary edema, shock or cardiopulmonary arrest. See also pulmonary edema under IId, and XIId, XIIf. Review at PMID 10193711, 16808550, 18083403, 21930637

Causative drugs

29
Ecstasy (MDMA)
II.a
V.a
VIII.a
X.a
X.b
XVI.c
XXII.b
XXXVIII.a
Electroconvulsive therapy
II.a
II.d
X.a
X.b
X.h
X.m
Energy drinks
II.a
VI.a
Entrectinib
II.a
III.a
V.b
Hydroxychloroquine
I.a
I.g
I.i
II.a
IV.a
VI.a
XI.a
XXIX.a
XXXIII.e
Imatinib
II.a
VI.a
X.a
XII.b
XII.r
XIV.a
XVI.e
XXII.b
XXIV.a
XXIV.b
XXIV.c
Immune checkpoint inhibitors (ICI) - ICI combinatorial Rx
I.a
I.m
II.a
II.c
II.d
III.a
IV.a
V.a
V.e
VI.c
VII.a
X.a
XI.a
XII.b
XIII.a
XIV.a
XIV.i
XV.e
XVI.h
XXI.a
XXII.b
XXIV.a
XXIV.b
XXIV.c
XXIV.d
XXIV.e
XXIV.h
XXIV.i
XXIV.j
XXIV.l
XXIV.o
XXIV.q
XXIV.v
XXIV.ab
XXIV.ac
XXIX.a
XXIX.i
XXX.h
XXXIII.f
XXXVI.f
XXXVI.q
XXXVI.v
Interleukin 2 (IL2)
II.a
Mesalazine-Mesalamine-5-aminosalicylic acid-5ASA-5-aminosalicylate
II.a
II.d
III.a
V.a
V.b
V.f
X.a
XII.a
XII.b
XII.n
XIV.a
XIV.d
XV.a
XXIV.a
XXIV.b
XXIV.c
XXIV.d
XXIV.j
XXIV.p
XXIV.s
XXVIII.m
XXXVI.b
XXXVI.m
Oxytocin
II.a
X.b
XXVIII.a
XXIX.a
XXIX.j
XXXVI.f
Ponatinib
II.a
III.a
XI.a
XIV.a
XXIV.b
Propofol
II.a
II.d
Sunitinib
II.a
II.c
XIV.a
Trastuzumab
I.a
I.g
II.a
VI.a
VII.a
X.f
XXIV.a
XXIV.b
XXIV.c
XXIV.j
XXIX.a
XXXVI.f
XXXVI.i
XXXVI.ac
XXXVIII.k